Module 9 Flashcards
The variation in individual response to medication is due to what factors?
Environment, genetics and disease state
_______ ______ are an important first step in determining interpatient variability to drug response.
Clinical trials
Phase 1 CT:
- __-____ _______ volunteers
- Evaluation of _________ and ___________
- ________ studies guide dosing
20-100 healthy volunteers
Evaluation of pharmacokinetics and pharmacodynamics
Animal studies guide dosing
Phase 2 CT:
- ____-______ patients with the _______
- ____-term trial to determine ______ and _____-_______
- ____-response is determined
300-500 patients with the disorder
Short term trial to determine efficacy and side effects
Dose-response is determined
Phase 3 CT:
- ____-_____ patients with the target disorder
- ______ verified and ___-term _____-______ evaluated
500-5000 patients with the target disorder
Efficacy verified and long-term side effects evaluated
Phase 4 CT - most important part.
PMS - post-market surveillance
Dose required to produce a response in 50% of the population
ED50
The ______ is often used as the initial dose for therapy.
ED50
How do we dose drugs that have a narrow therapeutic range?
Dose should initially be titrated - i.e. start low and increase slowly until the desired response is achievved
When is it okay to use the ED50 as a starting dose?
When the drug has a wide therapeutic range
Tests for toxic or lethal doses are carried out on who?
Animals
Dose in which 50% of animals experience drug toxicity.
TD50 - average toxic dose
Dose in which 50% of animals die
LD50 - average lethal dose
Indicator of a drug’s safety. How is it calculated?
Therapeutic index
LD50/ED50 = TI
or
TD50/ED50
What are the 7 factors that affect interpatient variation in response to drugs?
Body weight and composition Genetics Gender Race Kidney disease Liver disease Environment